Articles

Avosentan, an endothelin-A antagonist, decreases the urinary albumin excretion rate (UAER) in patients with diabetes and macroalbuminuria when added to standard therapy with an angiotensin-converting enzyme (ACE) inhibitor and/or angiotensin receptor blocker (ARB), according to results of a new study at 58 centers.

Giving people with type 2 diabetes the opportunity to help manage their care online can substantially improve their long-term blood sugar control, new research suggests. Clinic visits alone aren’t enough for many people with diabetes,

Primary- and secondary-prevention patients who consistently take their statin medication have a significantly lower risk of death than those who do not adhere to therapy, a new study has shown [1]. Individuals who took their medication at least 90% of the time had a 45% reduction in the risk of …

High-frequency telephone contact with a dietitian can be an effective method for supporting lifestyle modification in obese patients trying to lose weight, according to the results of a randomized, six-month, open-label study.

A new analysis of data from the Nurses’ Health Study shows that long-term intake of up to four or more cups of coffee per day was not associated with an increased risk for stroke and actually appeared to be protective against stroke in women who did not also smoke.

High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a new study. The results suggest that this procedure could be beneficial for those with poor prognoses and those with diabetes.

Less is more, that is the news coming out of a new study on the best way to spend your time when exercising. New research announced on Monday says that just a few moments of concentrated exercise weekly is as beneficial as thirty minutes of normal physical activity a day …

A rise in blood sugar levels causes poorer brain function in people with type 2 diabetes, according to a study that included nearly 3,000 people aged 55 and older at 52 sites in Canada and the United States.

A refined analysis of a major clinical trial indicates that treating patients with the cholesterol-lowering agent rosuvastatin dramatically reduces the incidence of stroke among patients with high levels of C-reactive protein when compared with patients taking placebo.

Hospitalized diabetic stroke patients who receive sulphonylurea therapy appear to be less likely to die and more likely to have a better outcome than patients who do not receive this type of therapy, according to data analyzed from a large patient population that was diagnosed with ischemic stroke.